Phosphate Concentrations and Modifying Factors in Healthy Children From 12 to 24 Months of Age
Open Access
- 2 July 2021
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (10) , 2865-2875
Abstract
Context Phosphate homeostasis and its modifiers in early childhood are inadequately characterized. Objective To determine physiological plasma phosphate concentration and modifying factors in healthy infants at 12 to 24 months of age. Design This study included 525 healthy infants (53% girls), who participated in a randomized vitamin D intervention trial and received daily vitamin D3 supplementation of either 10 or 30 μg from age 2 weeks to 24 months. Biochemical parameters were measured at 12 and 24 months. Dietary phosphate intake was determined at 12 months. Main Outcome Measures Plasma phosphate concentrations at 12 and 24 months of age. Results Mean (SD) phosphate concentration decreased from 12 months (1.9 ± 0.15 mmol/L) to 24 months (1.6 ± 0.17 mmol/L) of age (P < 0.001 for repeated measurements). When adjusted by covariates, such as body size, creatinine, serum 25-hydroxyvitamin D, intact and C-terminal fibroblast growth factor 23, mean plasma phosphate was higher in boys than girls during follow-up (P = 0.019). Phosphate concentrations were similar in the vitamin D intervention groups (P > 0.472 for all). Plasma iron was associated positively with plasma phosphate at both time points (B, 0.006 and 0.005; 95% CI, 0.004-0.009 and 0.002-0.008; P < 0.001 at both time points, respectively). At 24 months of age, the main modifier of phosphate concentration was plasma creatinine (B, 0.007; 95% CI 0.003-0.011, P < 0.001). Conclusion Plasma phosphate concentration decreased from age 12 to 24 months. In infants and toddlers, the strongest plasma phosphate modifiers were sex, iron, and creatinine, whereas vitamin D supplementation did not modify phosphate concentrations.Keywords
Funding Information
- the Sigrid Jusélius Foundation
- Research Council of Finland
- Swedish Research Council
- Novo Nordisk Foundation
- Folkhälsan Research Foundation
- Finnish Medical Foundation
- Victoriastiftelsen
- Orion Research Foundation
- Instrumentarium Science Foundation
- Paulo Foundation
- Paivikki and Sakari Sohlberg Foundation
- Juho Vainio Foundation
- Finnish Pediatric Research Foundation
- Finska Läkaresällskapet
- Stiftelsen Dorothea Olivia
- Karl Walter och Jarl Walter Perkléns minne
This publication has 42 references indexed in Scilit:
- High dose intravenous iron, mineral homeostasis and intact FGF23 in normal and uremic ratsBMC Nephrology, 2013
- Phosphate homeostasis and its role in bone healthPediatric Nephrology, 2012
- Differential modulation of the molecular dynamics of the type IIa and IIc sodium phosphate cotransporters by parathyroid hormoneAmerican Journal of Physiology-Cell Physiology, 2011
- New Finnish growth references for children and adolescents aged 0 to 20 years: Length/height-for-age, weight-for-length/height, and body mass index-for-ageAnnals of Medicine, 2010
- Recent advances in renal phosphate handlingNature Reviews Nephrology, 2010
- The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical propertiesScandinavian Journal of Clinical and Laboratory Investigation, 2004
- Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)2 vitamin D3American Journal of Physiology-Cell Physiology, 2002
- Local action of phosphate depletion and insulin-like growth factor 1 on in vitro production of 1,25-dihydroxyvitamin D by cultured mammalian kidney cells.Journal of Clinical Investigation, 1994
- Parathyroid hormone and calcitonin regulation of renal functionKidney International, 1974
- Blood Chemistry of Normal Full-term Infants in the First 48 Hours of LifeArchives of Disease in Childhood, 1965